2K Filling Foam

Hazard statements (CLP)

H222, H229, H315, H317, H319, H332, H334, H335, H351, H373

Code

Statements

H222

Extremely flammable aerosol

EU Classification

Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations

Physical hazards

Aerosol, Category 1 H222;H229 Extremely flammable aerosol. Pressurised container: May burst if heated.

Health hazards

Acute toxicity (inhalation:vapour) H332 Harmful if inhaled. Category 4 Skin corrosion/irritation, Category 2 H315 Causes skin irritation. Serious eye damage/eye irritation, H319 Causes serious eye irritation. Category 2 Respiratory sensitisation, Category 1 H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitisation, Category 1 H317 May cause an allergic skin reaction. Carcinogenicity, Category 2 H351 Suspected of causing cancer. Specific target organ toxicity – Single H335 May cause respiratory irritation. exposure, Category 3, Respiratory tract irritation Specific target organ toxicity – H373 May cause damage to organs through Repeated exposure, Category 2 prolonged or repeated exposure. Full text of H- and EUH-statements: see section 16

Adverse physicochemical, human health and environmental effects

No additional information available

2.2 Label elements

Labelling according to The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations

Signal word

Danger

Contains

1,2-Benzenedicarboxylic acid, 3,4,5,6-tetrabromo-, 1-[2-(2-hydroxyethoxy)ethyl] 2-(2- hydroxypropyl) ester, polymers with; Reaction products of phosphoryl trichloride and 2- methyloxirane; Ethanediol; Diphenylmethane diisocyanate, isomers and homologues

Hazard statements

H222 Extremely flammable aerosol. H229 Pressurised container: May burst if heated. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H332 Harmful if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 May cause respiratory irritation. H351 Suspected of causing cancer. H373 May cause damage to organs through prolonged or repeated exposure.

Prevention

P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P251 Do not pierce or burn, even after use. P260 Do not breathe mist, spray, vapours. P280 Wear protective gloves, eye protection.

Response

P342+P311 If experiencing respiratory symptoms: Call doctor. P308+P313 IF exposed or concerned: Get medical advice/attention.

Storage

P410+P412 Protect from sunlight. Do not expose to temperatures exceeding 50 °C, 122 °F.

Additional information

As from 24 August 2023 adequate training is required before industrial or professional use.

Other hazards which do not result in classification

Persons already sensitised to diisocyanates may develop allergic reactions when using this product. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII. This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII. The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %